2010Food ScienceRequires access

Ninety-day Rat Feeding Study of 5'-Nucleotide

Junbo Wang

Open publisher page 0 citations

Abstract

Objective: To explore the safety of 5’-nucleotide in rats. Methods: Totally 96 rats were randomly divided into 6 groups and fed diet containing 5-’nucleotide at doses of 0, 0.01, 0.04, 0.16, 0.64 g/kg bw and 1.28 g/kg bw for 90 consecutive days. The changes of body weight, dietary intake amount, food utilization rate, blood pressure, blood routine, biochemical parameters, and pathological results of the rats were recorded at intervals of one week during the administration of 5’- nucleotide. Results: No obvious difference in total body weight gain, total dietary intake amount, food utilization rate and systolic blood pressure was observed between 5’-nucleotide treatment groups and control group. However, compared with the rats in control group, body weights of male rats in nucleotide treatment group exhibited a significant increase in the first 4 weeks (P 0.05). Similarly, total food utilization rates of the rats treated with 5’-nucleotide at doses of 0.01, 0.04 g/kg bw and 0.16 g/kg bw exhibited significantly higher than that of control group in the first 2 weeks (P 0.05). In addition, compared with the control group, white blood cells, red blood cells, hemoglobin, platelets, total protein, albumin, alanine transaminasse, triglyceride of male rats also revealed a significant difference. However, all of these values were still in the normal range. No histopathological change was observed in kidney and other organs or tissues. Conclusion: It is safety to rats fed 5’-nucleotide at the dose of 0.01 - 1.28 g/kg bw.

About this research paper

What this paper is about

Objective: To explore the safety of 5’-nucleotide in rats. Methods: Totally 96 rats were randomly divided into 6 groups and fed diet containing 5-’nucleotide at doses of 0, 0.01, 0.04, 0.16, 0.64 g/kg bw and 1.28 g/kg bw for 90 consecutive days. The changes of body weight, dietary intake amount, food utilization rate, blood pressure, blood routine, biochemical parameters, and pathological results of the rats were recorded at intervals of one week during the administration of 5’- nucleotide. Results: No obvious difference in total body weight gain, total dietary intake amount, food utilization rate and systolic blood pressure was observed between 5’-nucleotide treatment groups and control group. However, compared with the rats in control group, body weights of male rats in nucleotide treatment group exhibited a significant increase in the first 4 weeks (P 0.05). Similarly, total food utilization rates of the rats treated with 5’-nucleotide at doses of 0.01, 0.04 g/kg bw and 0.16 g/kg bw exhibited significantly higher than that of control group in the first 2 weeks (P 0.05). In addition, compared with the control group, white blood cells, red blood cells, hemoglobin, platelets, total protein, albumin, alanine transaminasse, triglyceride of male rats also revealed a significant difference. However, all of these values were still in the normal range. No histopathological change was observed in kidney and other organs or tissues. Conclusion: It is safety to rats fed 5’-nucleotide at the dose of 0.01 - 1.28 g/kg bw.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To explore the safety of 5’-nucleotide in rats. Methods: Totally 96 rats were randomly divided into 6 groups and fed diet containing 5-’nucleotide at doses of 0, 0.01, 0.04, 0.16, 0.64 g/kg bw and 1.28 g/kg bw for 90 consecutive days. The changes of body weight, dietary intake amount, food utilization rate, blood pressure, blood routine, biochemical parameters, and pathological results of the rats were recorded at intervals of one week during the administration of 5’- nucleotide. Results: No obvious difference in total body weight gain, total dietary intake amount, food utilization rate and systolic blood pressure was observed between 5’-nucleotide treatment groups and control group. However, compared with the rats in control group, body weights of male rats in nucleotide treatment group exhibited a significant increase in the first 4 weeks (P 0.05). Similarly, total food utilization rates of the rats treated with 5’-nucleotide at doses of 0.01, 0.04 g/kg bw and 0.16 g/kg bw exhibited significantly higher than that of control group in the first 2 weeks (P 0.05). In addition, compared with the control group, white blood cells, red blood cells, hemoglobin, platelets, total protein, albumin, alanine transaminasse, triglyceride of male rats also revealed a significant difference. However, all of these values were still in the normal range. No histopathological change was observed in kidney and other organs or tissues. Conclusion: It is safety to rats fed 5’-nucleotide at the dose of 0.01 - 1.28 g/kg bw.

Key concepts: Triglyceride, Blood pressure, Nucleotide, Internal medicine, Albumin, Endocrinology, Hemoglobin, Body weight

Related papers

Back to paper searchBrowse research topicsOriginal source
Ninety-day Rat Feeding Study of 5'-Nucleotide — Research Paper | ScholarLens